Key result
82Rb imaging shows intense uptake in metastatic renal cell carcinoma thoracic lesions lacking 18F-FDG uptake.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
82Rb imaging may demonstrate intense uptake in metastatic renal cell carcinoma where 18F-FDG does not, suggesting potential utility in molecular imaging of this condition.
Renal cell carcinoma has a variable uptake of F-FDG resulting in poor sensitivity and limited clinical application. There is intense interest in improved molecular imaging of this condition. We present a case of a 64-year-old man with known metastatic renal cell carcinoma found to have intense uptake of Rb but not F-FDG in multiple thoracic metastases seen on imaging performed to assess myocardial hibernation.
No takes yet. Share an insight, caveat, or question.
Murthy et al. (2013) conducted a case report in Metastatic renal cell carcinoma (n=1). 82Rb imaging vs. 18F-FDG imaging was evaluated on Tracer uptake in thoracic metastases. Imaging of a 64-year-old man with metastatic renal cell carcinoma demonstrated intense uptake of 82Rb but not 18F-FDG in multiple thoracic metastases.
Synapse has enriched 10 related papers. Consider them for comparative context: